1. Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Research & Therapy 2008; 10 Suppl 2.

2. Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Research & Therapy 2009; 11: 227.

3. Anauate MC, Torres LM, Veríssimo de Mello SB. Effect of Isolated Fractions of Harpagophytum procumbens D.C. (Devil’s Claw) on COX-1, COX-2 Activity and Nitric Oxide Production on Whole-Blood Assay. Phytother Res 2010; 24: 1365–1369.

4. Anonymous. Harpagophytum procumbens (Devil’s Claw).
Alternative Medicine Review 2008; Volume 13, Number 3, pp 248–252.

5. Bélaiche P. Étude clinique de 630 cas d’arthrose traits par le nébulisant aqueux d’Harpagophytum procumbens (Radix).Conférence faite au III Congrès International de Phytothérapie à Paris, Octobre 1981.

6. Brendler T, Gruenwald J, Ulbricht C, Basch E. Devil’s Claw (Garpagophytum procumbens DC): An evidence-based systematic review by the Natural Standard Research Collaboration. Journal of Herbal Pharmacitherapy 2006; vol 6(1).

7. Brien S, Lewith GT, McGregor G. Devil’s Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: A reviw of efficacy and safety. The Journal of Alternative and Complementary Medicine 2006; vol 12, no 10, pp 981-993.

8. Cameron M, Gagnier JJ, Little CV, Parsons TJ, Blümle A, Chrubasik S. Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Phytotherapy research 2009; 23: 1497-1515.

9. Chantre P, Cappelaere A, Leblan D, Guedon D, Vandermander J, Fournie B. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 2000; vol 7(3), pp 177-183.

10. Chrubasik S, Zimpfer CH, Schütt U, Ziegler R. Effectiveness of Harpagophytum procumbens in treatment of acute low back pain. Phytomedicine 1996; vol 3(1), pp 1-10.

11. Chrubasik S, Thanner J, Künzel O, Conradt C, Black A, Pollak S. Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin® in patients with pain in the lower back, knee or hip. Phytomedicine 2002; 9: 181-194.

12. Chrubasik S, Junck H, Breitschwerdt H, Conradt Ch, Zappe H. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized, placebo-controlled, double-blind study. European Journal of Anaesthesiology 1999; 16: 118-129.

13. Chrubasik S, Schmidt A, Junck H, Pfisterer M. Wirksamkeit und Wirtschaftlichkeit von Teufelskrallenwurzelextrakt bei rückenschmerzen: Erste ergebnisse einer therapeutischen kohortenstudie. Forsch Komplementärmed 1997, 4: 332-336.

14. Cordier W, Steenkamp V. Drug interactions in African herbal remedies. Drug Metab Drug Interact 2011; 26(2).

15. Eklund Å. Harpagophytum procumbens – Djävulsklo. Institutionen för läkemedelskemi, Avdelningen för farmakognosi, Uppsala universitet, 2006.

16. Frerick H, Biller A, Schmidt U. Stufenschema bei coxarthrose. Doppelblindstudie mit Teufelskralle. Kassenartzt 2001; 5: 31-34.

17. Frerick H, Biller A, Schmidt U. Double-blind study with Devil’s claw – graduated treatment regimen in osteoarthritis of the hip. Interdisciplinary Medical Research Organisation, Cologne and Dr. Loges + Co GmbH Arzneimittel, Winsen.

18. Gagnier JJ, Chrubasik S, Manheimer E. Harpgophytum procumbens for osteoarthritis and low back pain: A systematic review. BMC Complementary and Alternative Medicine 2004; 4: 13.

19. Gagnier JJ, van Tulder MW, Berman B, Bombardier C. Herbal Medicine for Low Back Pain. A Cochrane Review. Spine 2007; 32(1): 82-92.

20. Georgiev MI, Alipieva K, Orhan IE. Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems. Phytotherapy research 2011 (Wiley Online Library).

21. Göbel H, Heinze A, Ingwersen M, Niederberger U, Gerber D. Harpagophytum-extrakt LI 174 (Teufelskralle) bei der Behandlung unspezifischer Rückenschmerzen. Schmerz 2001; 15: 10-18.

22. Haglund O. Djävulsklo – ett spännande alternative vid ledbesvär. Medicinsk access 2009; 1: 44-47.

23. Haglund O. Artros – den dolda folksjukdomen. Medicinsk access 2008; 6: 20-26

24. HancockCM, Riegger-Krugh C. Modulation of Pain in Osteoarthritis. The Role of Nitric Oxide. Clin J Pain 2008; 24(4): 353-365.

25. Kaszkin M, Schneider B, Loew D. Kasuistik: Hoch dosieerter Harpagophytum-Spezialextrakt zur Remissionserhaltung des Morbus Chrohn. Ärzlezeitschrift für Naturheilverfahren 2004; 45(2): 102-106.

26. Laudahn D, Walper A. Efficacy and tolerance of Harpagophytum extract LI 174 in patients with chronic non-radicular back pain. Phytotherapy research 2001; 15: 621-624.

27. Pinget M, Lecomte A. Die Wirkung der “Harpagophytum Arkocaps” bei degenerativen Rheuma. Naturheilpraxix 1997; 2.

28. Roman-Blas JA, Jimenez SA. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. OsteoArthritis and Cartilage 2006; 14: 839-848.

29. Schendel UM. Arthrose-Therapie: Verträglich geht es auch. Studie mit Teufelskrallenextrakt. Der Kassenarzt 2001; 29/30: 36-39.

30. Schmelz H, Haemmerle HD, Springorum HW. Analgetische Wirksamkeit eines Teufelskrallenwurzel Extraktes bei verschidenen chronisch-degenerativen Gelenkerkrankungen. Rheumatherapie mit Phytopharmaka. Stuttgart. Hippokrates 1997; 86-89.

31. Stoltz Denner S. A review of the efficacy and safety of Devil’s Claw for pain associated with degenerative musculoskeletal diseases, rheumatoid, and osteoarthritis. Holistic Nursing Practice 2007; July/August: 203-207.

32. Warnock M, McBean D, Suter A, Tan J, Whittaker P. Effectiveness and safety of Devil’s Claw tablets in patients with general rheumatic disorders. Phytotherapy Research 2007; 21: 1228-1233.

33. Wegener T, Lüpke NP. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil’s claw (Harpagophytum procumbens DC.). Phytotherapy Research 2003; 17(10): 1165-1172.

34. Vlachojannis J, Roufogalis BD, Chrubasik S. Systematic review on the safety of Harpagophytum preparations for osteoarthritic and low back pain. Phytotherapy Research 2008; 22: 149-152.